Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research
Cytotherapy
· Elsevier
Abstract
Publication date: Available online 29 October 2026 Source: Cytotherapy Author(s): Jun Liu, Shin-Young Park, Hirotomo Nakahara, Yembur Ahmad, Ziyang Shen, Suhayla Sarhan, Stephanie Ferrara, Vanessa Anjurthe, Kristi Georgilas, Sarah Nikiforow, Zankar Desai, Shang-Chuen Wu, Ryan P. Jajosky, Sarthak Saha, Nelya Christiansen, Kendra B. Munkacsy, Jiajia Li, Hongbo R Luo, Sophia Adamia, Sean R. Stowell
Read at publisher →
Cite
Get new articles on “Transplantation”
Subscriptions, keyword tracking and favourites — in the Articlium Telegram bot.
Open in Telegram
Citation
✕
ГОСТ
APA
MLA
BibTeX
Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research. // Cytotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all
Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research. Cytotherapy. https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all
“Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research.” Cytotherapy.
@article{article43154,
title = {Clinical apheresis waste yields a renewable biobank of patient-derived CD34+ stem cells for beta-hemoglobinopathy research},
journal = {Cytotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S1465324926010169?dgcid=rss_sd_all}
}